Global Antibody Drug Conjugates Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI613945
  • May 03, 2019
  • Global
  • 92 pages
  • QY Market Research
                                              "The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Antibody Drug Conjugates market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Antibody Drug Conjugates market."
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. 
The preparation process of ADCs involves great difficulty, inspite of these hurdles recently approved ADCs have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADCs that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.

The global Antibody Drug Conjugates market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antibody Drug Conjugates volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody Drug Conjugates market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    F. Hoffman-La Roche
    Novartis AG
    Takeda Pharmaceutical
    Pfizer
    Seattle Genetics
    Genentech
    Immunogen
    Progenics Pharmaceuticals
    Bayer Healthcare Pharmaceuticals

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Adcetris
    Kadcyla

Segment by Application
    Breast Cancer
    Lymphoma
 

Table of Contents

Executive Summary
1 Antibody Drug Conjugates Market Overview
    1.1 Product Overview and Scope of Antibody Drug Conjugates
    1.2 Antibody Drug Conjugates Segment by Type
        1.2.1 Global Antibody Drug Conjugates Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Adcetris
        1.2.3 Kadcyla
    1.3 Antibody Drug Conjugates Segment by Application
        1.3.1 Antibody Drug Conjugates Consumption Comparison by Application (2014-2025)
        1.3.2 Breast Cancer
        1.3.3 Lymphoma
    1.4 Global Antibody Drug Conjugates Market by Region
        1.4.1 Global Antibody Drug Conjugates Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Antibody Drug Conjugates Market Size
        1.5.1 Global Antibody Drug Conjugates Revenue (2014-2025)
        1.5.2 Global Antibody Drug Conjugates Production (2014-2025)

2 Global Antibody Drug Conjugates Market Competition by Manufacturers
    2.1 Global Antibody Drug Conjugates Production Market Share by Manufacturers (2014-2019)
    2.2 Global Antibody Drug Conjugates Revenue Share by Manufacturers (2014-2019)
    2.3 Global Antibody Drug Conjugates Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Antibody Drug Conjugates Production Sites, Area Served, Product Types
    2.5 Antibody Drug Conjugates Market Competitive Situation and Trends
        2.5.1 Antibody Drug Conjugates Market Concentration Rate
        2.5.2 Antibody Drug Conjugates Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Antibody Drug Conjugates Production Market Share by Regions
    3.1 Global Antibody Drug Conjugates Production Market Share by Regions
    3.2 Global Antibody Drug Conjugates Revenue Market Share by Regions (2014-2019)
    3.3 Global Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Antibody Drug Conjugates Production
        3.4.1 North America Antibody Drug Conjugates Production Growth Rate (2014-2019)
        3.4.2 North America Antibody Drug Conjugates Production, Revenue, Price and Gross Margin (2014-2019)
   ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form